Biotechnology and Management. The healthcare system costs the United States $2.7 trillion -- 17.5 percent of gross domestic product -- in 2010. More than 40 percent of that cost -- about $1 billion -- comprises pharmaceutical, diagnostics, biotechnology and medical devices. Related articles Inspiration - Carnegie Mellon ETC Projects (designgames12.wordpress.com) Carnegie Mellon University-Rwanda Launches Graduate … Continue reading Carnegie Mellon Program in Biotechnology and Management: Healthcare spending and GDP
You must be logged in to post a comment.